Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Autologous stem cell transplantation (ASCT)"'
Autor:
Michele Clerico, Simone Ferrero, Beatrice Alessandria, Gian Maria Zaccaria, Elisa Genuardi, Simone Ragaini, Rita Tavarozzi, Federica Cavallo, Stefan Hohaus, Gerardo Musuraca, Angelo Michele Carella, Caterina Stelitano, Monica Tani, Gianluca Gaidano, Jacopo Olivieri, Sara Veronica Usai, Sara Galimberti, Francesca Re, Michael Mian, Claudia Castellino, Vincenzo Pavone, Andrea Evangelista, Benedetto Bruno, Sergio Cortelazzo, Roberto Passera, Marco Ladetto
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract In the frontline high-dose phase 3 FIL-MCL0208 trial (NCT02354313), 8% of enrolled mantle cell lymphoma (MCL) patients could not be randomised to receive lenalidomide (LEN) maintenance vs observation after autologous stem cell transplantatio
Externí odkaz:
https://doaj.org/article/0fb90bbb8fcd4300b5901399a273825b
Autor:
Paola Stefanoni, Monica Galli, Laura Paris, Alessandro Rambaldi, Nicola Pittalis, Gianluca Cavallaro, Chiara Pavoni
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 16, Iss 1 (2024)
We performed a monocentric, retrospective real-world analysis (RWA) to evaluate the feasibility and the main results of an autologous stem cell transplantation (ASCT)-based program in a cohort of 90 newly diagnosed multiple myeloma patients aged > 65
Externí odkaz:
https://doaj.org/article/388f1920e3554d6c8e62cb8e255dc256
Publikováno v:
Shanghai Jiaotong Daxue xuebao. Yixue ban, Vol 43, Iss 10, Pp 1282-1288 (2023)
Objective·To analyze the clinical characteristics and prognostic risk factors of patients with diffuse large B-cell lymphoma (DLBCL), and evaluate the prognostic effects of autologous stem cell transplantation (ASCT) and rituximab maintenance therap
Externí odkaz:
https://doaj.org/article/d90486bdc9924d8e895167bf84be3284
Autor:
Lisa K Isbell, Roswitha Uibeleisen, Alexander Friedl, Elvira Burger, Tatja Dopatka, Florian Scherer, Andras Orban, Eliza Lauer, Natalie Malenica, Inna Semenova, Annika Vreden, Elke Valk, Julia Wendler, Simone Neumaier, Heidi Fricker, Abed Al Hadi El Rabih, Cora Gloggengießer, Daniela Hilbig, Sabine Bleul, Joachim Weis, Dennis Gmehlin, Matthias Backenstrass, Sebastian Wirtz, Gabriele Ihorst, Jürgen Finke, Gerald Illerhaus, Elisabeth Schorb
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Older primary central nervous system lymphoma (PCNSL) patients have an inferior prognosis compared to younger patients because available evidence on best treatment is scarce and treatment delivery is challenging due to comorbiditi
Externí odkaz:
https://doaj.org/article/12be11ae6eaa40df980e3443b49886e9
Autor:
Andrea M. Cappellano, Natalia Dassi, Bruna M. Mançano, Sidnei Epelman, Daniela B. Almeida, Sergio Cavalheiro, Patricia A. Dastoli, Maria T. S. Alves, Jardel M. Nicacio, Marcos D. S. Costa, Frederico A. Silva, Simone S. Aguiar, Maria L. Figueiredo, Michael Chen, Nasjla S. Silva, Jonathan L. Finlay
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundNon-germinomatous germ cell tumors (NGGCT) accounts for one third of intracranial GCT. While the germinoma group have an excellent overall survival, the standard of practice for children with NGGCT is still under evaluation.AimsDescribe the
Externí odkaz:
https://doaj.org/article/3323d3b79fc54705bea05e4f45b07baf
Autor:
Danaë Martinez Flores, Dilara Akhoundova, Katja Seipel, Myriam Legros, Marie-Noelle Kronig, Michael Daskalakis, Ulrike Bacher, Thomas Pabst
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1616 (2024)
Gemtuzumab ozogamicin (GO), a CD33-targeting antibody drug conjugate, previously showed longer relapse-free survival when combined with induction chemotherapy in patients with favorable-risk acute myeloid leukemia (AML). In this patient population, c
Externí odkaz:
https://doaj.org/article/b66403e51acf4363a6c98412cb54222d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Julia Wendler, Christopher P. Fox, Elke Valk, Cora Steinheber, Heidi Fricker, Lisa K. Isbell, Simone Neumaier, Jessica Okosun, Florian Scherer, Gabriele Ihorst, Kate Cwynarski, Elisabeth Schorb, Gerald Illerhaus
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (PCNSL) is a rare disorder with an increasing incidence over the past decades. High-level evidence has been reported for the MATRix regimen (high-dose met
Externí odkaz:
https://doaj.org/article/7a730aa701ea4f188fc9c25f437b5b41
Publikováno v:
Egyptian Journal of Medical Research, Vol 3, Iss 2, Pp 137-143 (2022)
Sensitivitytosalvage chemotherapy is one of the strongest predictors of OS and PFS after high-dose therapy with autologous bone marrow or peripheral blood stem cell transplantation (ABMT) in relapsed or refractory non-Hodgkin’slymphoma. Consequentl
Externí odkaz:
https://doaj.org/article/4fffa203d7554c0698c53507a67e48b8
Autor:
Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri Taleghani, Urban Novak, Thomas Pabst
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023)
Introduction: Autologous stem cell transplantation (ASCT) following high-dose chemotherapy is applied for patients with relapsed/refractory (r/r) DLBCL. However, prognosis of relapsing DLBCL post-ASCT remained poor until the availability of CAR-T cel
Externí odkaz:
https://doaj.org/article/601b18a0eecb4fb3aca4d1502d36b86d